| Tag | Content |
|---|
EnhancerAtlas ID | HS091-15880 |
Organism | Homo sapiens |
Tissue/cell | HepG2 |
Coordinate | chr16:167380-169120 |
Target genes | | Number: 24 | Name | Ensembl ID |
|
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| CTCF | MA0139.1 | chr16:167926-167945 | CTGCCACCAGGGGGAGTTG | + | 6.07 | | ZEB1 | MA0103.3 | chr16:168840-168851 | CCCACCTGCCC | + | 6.14 | | ZEB1 | MA0103.3 | chr16:168979-168990 | CCCACCTGCCC | + | 6.14 | | ZEB1 | MA0103.3 | chr16:169099-169110 | CCCACCTGCCC | + | 6.14 |
|
| | Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
| SE_12716 | chr16:168751-168940 | CD34_fetal | | SE_15136 | chr16:168824-171565 | CD4_Memory_Primary_7pool |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 3 | ID | Chromosome | Start | End |
| GH16I000117 | chr16 | 167821 | 168010 | | GH16I000119 | chr16 | 168213 | 168300 | | GH16I000118 | chr16 | 168752 | 171565 |
|
Enhancer Sequence | AAGATGCATA ATTCTAATTA ATTGAGACGA CTTTCTAAGG AAAGCTGTTT AGAGCTATTC 60
TACTTCAGGC ATGGCAAAAG TCCCCAGAAT ACAGCACCAA GGTCTTGGAA AAGCAATGAA 120
TGCCTTTGCT CTGGAGGCGT GCCTACTGCA TGGGCAAAGT CACAACTATG ACAAGAGTGG 180
GAAGGTCAGT GCTCTGACCC CCTCGCCCCC CCGCTAACAG AAGTGAGCTG ACAATGCCCA 240
CAGGGGACGA GATGGAGAGG GGCATAAATG GGTGGAGGAC CCAGACCCAC ACCCCCACTG 300
CCTTCCCGTG CCCGCCTGCA TCCACCAGGC TGTATCTGCT AAGTATGACG CATACTCAGA 360
ACAATTGAGG GACAGGACGA TGTTCAGGGA CAGCCAAGCC CTGAGCAGGG CCCAGGTGAG 420
GCAGGCCAGC AAGTCCTAAT TTCTGTGCTC CCGGTTCTGG CATCCAGCCA GCTTCACAAG 480
GACCAGGGCG CTCAAGGGAA GCATTCCAAG GGGCACGGGG GAACTCTTCA AAGCCAACTA 540
CAAGTTCTGC CACCAGGGGG AGTTGGGGCC CCAGGCTGCC CTGGCACCCA TCCCCTACCC 600
CTGACTGCCA CTCCTGTCTA CAGGGTGTGA CCGCGGGCAG GCTGCCAACT CTCCCCTTCA 660
TTGCCTACAG GTAGGGGACT GTGCCCCAGC TGTGGAGGCT GTGATGAGAA GGGAGGGTGC 720
GGTACAGGGG ACCAGGCTCA TCAACCGCCT CAGAAACTCC TTCCATGGAG GTTCACGAAT 780
AACACCACAG AACCTCCCAG AATTGCTGGA TCTGTATAAA TGTAGCTAAA TCCTACGTTA 840
CTGTGTTCGA CCCTTCAGAA TCTTAGTAAT GCCATCACTG ATCCTGCCTG TATGCAGAGA 900
GCTGACTGGC AGGCTCTGGT GTACAAGTTC CCTTCATCCT GCTAACAAGA TGAGTTCCTC 960
AGTGCTATGA CACCTATTCA TCAAGAGAAC ATATAGAGAG GGTTTAGCAG AAAAATAAGT 1020
GCTAAATAAT ACTAATATTA GCTACTAGAG TGTCTTGTAA TAAATAAGAG GAAATGCTTG 1080
CACCACACTG TAGAAAATTC AAGGGTTTCA CGATGCTAGT TAACTCACTA TCTTGGCCTC 1140
CCCTGGAAAC AGACATCCTA CATATGAAGG GGAGGGCCAC AGTCAGTAGA GACCTAGAAT 1200
GCAGACTGTA AAAGCTAGGG ACAGGGACTG AAGCACCTGT CTTCAGGGGC AAGAACACCT 1260
GTCTCTTTTT CTACTGGACT CTCTGGGTTT ATGAAGATGC ACAGTTCATA CCAAGTGTCT 1320
AATCAGGTCT CCTGCCCAGT ACCTTCACCA GAGCTGGTGT CAGCCTCAGT TCTGAGCCCC 1380
CCAGAGCCAG AATGGACCAG GCCTGCCGGC CCAGGGAGAG CCACATCTGC CCAGAGGGTC 1440
TGTGCATGCC CAGGGAGAAC CCCACCTGCC CAAGGACAGA CGCATCTGCC CAGGGGAAGC 1500
CACACCTGCC CAGGGGGAGC CACACCTTCC CAGAGGGTCT GTACCTGCCC AGGGGAAGCC 1560
ACATCTGCCC AGGGGAAGCC AAATCTACCC AGGGGGAGCC CCACCTGCCC AAGGAGAGCC 1620
ACACCTGCCC AGGGGAAGCC ACACCTGCCC AAGGAGAGCC ACACCTGCCC AAGGAGAGCC 1680
ACACCTGCCC AAGGAGAGCC ACATCTGCCC AGGGAGAGCC CCACCTGCCC AGGGAGAGCC 1740
|
